Crowdly

enable recruitment of human immune effector mechanisms such as complement

activation and Fc receptor‑mediated cytotoxicity

reduce immunogenicity and prevent the formation of anti‑drug antibodies

standardise dosing behaviour across monoclonal antibody therapies

Increased activation of autoreactive B cells due to permissive responses to weak self‑antigen interactions

Under normal circumstances, weak interactions between B‑cell

receptors and self‑antigens fail to trigger full activation due to

signalling thresholds that enforce tolerance. In a genetically modified system,

B cells show normal development and receptor diversity but require

significantly less signalling input for activation. Over time, this system

develops circulating autoantibodies and immune complex‑mediated

pathology.

What is the most likely immunological consequence of

lowering this activation threshold?

Reduced antibody binding strength, limiting immune complex formation

Inability to complete B‑cell activation due to impaired co‑stimulatory signalling

Enhanced deletion of autoreactive B cells through stricter selection mechanisms

Primary immune responses initially generate IgM antibodies

with relatively low intrinsic affinity, while later times in responses reveal higher-affinity

IgG antibodies. Despite this difference, IgM antibodies can efficiently

neutralise pathogens early in infection.

Which explanation BEST accounts for the functional

effectiveness of IgM in this context?

IgM

undergoes somatic hypermutation at rare, key residues prior to class switching

IgM

is preferentially selected for high-affinity variants during early germinal

centre responses

The

multivalent pentameric structure of IgM provides high avidity through

cooperative binding

Comparable

intrinsic affinity exists between IgM and IgG despite structural differences

Both SARS‑CoV and SARS‑CoV‑2

infect human cells by engaging ACE2, yet SARS‑CoV‑2 exhibits more efficient

transmission and cell entry. SARS-CoV-2 has additional features in its spike

protein which influence how efficiently the virus can enter its host cells.

Which molecular feature most clearly contributes to this

difference?

Exclusive

use of a distinct cellular receptor by SARS‑CoV-2 enhancing entry efficiency

Presence

of a polybasic cleavage site in the SARS‑CoV‑2 spike protein enhancing entry efficiency

Inability

of SARS‑CoV‑2 to bind ACE2 without auxiliary receptors, which

enhances entry efficiency

Absence

of spike protein cleavage sites in SARS‑CoV‑2 enhancing entry efficiency

A hospital microbiology lab identifies a strain of

Acinetobacter

baumannii

with decreased sensitivity to a carbapenem antibiotic. Molecular

testing shows a truncating mutation in a gene encoding an outer‑membrane

channel protein that normally permits passive diffusion of certain antibiotics

into the bacterium.

Which resistance strategy does this mutation most directly

represent?

Less

antibiotic entering the periplasm of the cell

Enzymatic

breakdown of the antibiotic molecule

Structural

modification of the antibiotic’s binding site

Increase

efflux of the antibiotic

A pharmaceutical company has developed a new antimicrobial

that is active against multidrug-resistant organisms. In clinical practice,

these infections are typically treated with existing agents that are effective

but associated with significant toxicity or resistance concerns. When seeking

regulatory approval, the company designs its pivotal trials as non-inferiority

studies rather than superiority trials.

Which rationale best explains this choice?

Demonstrating

comparable efficacy is sufficient when the new agent offers advantages such as

improved safety or activity against resistant strains

Regulatory

agencies do not allow superiority trials for antimicrobial drugs

Non-inferiority

trials are chosen primarily because they require fewer patients and simpler

study designs

Superiority

trials are not possible because resistant infections are too uncommon

The effectiveness of prior immunity against influenza

viruses declines over time, necessitating periodic updates to vaccine

formulations. Thus, seasonal vaccines must be created each year.

What evolutionary process most directly explains

this phenomenon?

Accumulation

of small mutations in surface antigens reduces antibody recognition

Rapid

turnover of viral internal proteins eliminates immune memory

Complete

immune escape occurs with each seasonal outbreak

Annual

emergence of entirely new influenza subtypes replaces circulating strains

Acinetobacter baumannii s

patient in intensive care has a bloodstream infection caused by a carbapenem-resistant

train. Initial

treatment uses colistin, a polymyxin antibiotic. During treatment, colistin

resistance evolves. What is the most likely mechanism of colistin resistance?

Mutation

pmrB

that lead to increased production of a phosphoethanolamine

transferase PmrC

Mutation

resulting in a missense amino acid substitution in the target RNA polymerase

Mutation

in the 16S ribosomal RNA gene, leading to an altered ribosomal structure

Acquisition

of a new beta-lactamase

Acinetobacter baumannii

A 65-year-old patient in the ICU develops a bloodstream

infection with

. Laboratory testing shows reduced

susceptibility to multiple carbapenems. Further investigation reveals that the

isolate carries the

blaKPC

gene on a conjugative plasmid and produces a

carbapenemase enzyme that hydrolyzes beta-lactam antibiotics. The isolate

remains susceptible to colistin.

Which general mechanism most likely explains the reduced

carbapenem susceptibility in this strain?

Altered

antibiotic target

Reduced

antibiotic uptake

Increased

antibiotic degradation

Increased

antibiotic efflux

During the 1918 influenza pandemic, viral variants emerged

with altered sialic acid receptor preference, reflecting adaptation to human

hosts. Changes in receptor binding can influence where in the respiratory tract

the virus replicates and how efficiently it spreads between individuals.

Which change would most plausibly explain how this host

adaptation increased both transmission and pathogenic impact at the population

level?

Reduced

binding to receptors in the lower respiratory tract, limiting severe disease

Increased

binding to receptors predominantly found in the lower respiratory tract,

enhancing tissue invasion

Increased

binding to receptors predominantly found in the upper respiratory tract,

facilitating efficient person-to-person spread

Acquisition

of multiple basic amino acids in the haemagglutinin cleavage site, increasing

intracellular activation